ArticleCureus2026
Bridging Access Gaps in Radiotherapy: Knowledge-Based Planning in a Resource-Constrained Clinical Setting.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background/purposeRadiotherapy access in low- and middle-income countries (LMICs) is severely limited by shortages of trained personnel, high patient volumes, and large waiting times for manual treatment planning. Knowledge-based planning (KBP) has shown promise in high-income settings, yet its feasibility in resource-constrained environments remains underexplored. This study aimed to evaluate the feasibility of adapting a KBP model developed at a high-income institution for clinical use at Liga Nacional Contra el Cáncer (LNCC) in Guatemala for gynecological radiotherapy planning. MATERIALS AND
methodsA RapidPlan KBP model (Varian-Siemens Healthineers, Palo Alto, CA, USA) originally developed at Washington University in St. Louis using data from over 150 patients was adapted and augmented with 118 gynecological cases from the Instituto Nacional de Cancerología (INCAN), reflecting local contouring variability and clinical heterogeneity. Cases were categorized into three planning groups based on planning target volume (PTV) geometry: pelvic only, pelvic with inguinal nodes, and pelvic with inguinal and paraaortic nodes. A validation cohort of 25 gynecological cancer patients was used to compare KBP-generated plans against manual plans produced by four dosimetrists (two junior, two senior). Plans were evaluated using a dosimetric scorecard tool adapted from Varian Medical Affairs, assessing PTV coverage, organ at risk (OAR) sparing (bladder, rectum, and femoral heads), total planning time, plan quality efficiency score (total score/planning time), gamma passing rates (3%/2 mm), and monitor units.
resultsOverall plan quality was comparable between KBP-generated and manually generated plans across all planners, with no systematic differences in target coverage or OAR sparing. The KBP model produced the highest scores for rectal dose metrics compared to manual plans. All plans achieved similar gamma passing rates (mean 99.6%). The mean monitor unit was 264 ± 57 MU across all planners. Importantly, the KBP model significantly reduced plan creation time, resulting in higher plan quality efficiency scores, demonstrating that equivalent clinical quality can be achieved more rapidly.
conclusionKBP can be successfully adapted from a high-income institution for use in an LMIC setting, maintaining clinical plan quality while substantially reducing planning time. This approach supports increased throughput and more equitable access to high-quality radiotherapy in resource-constrained environments, even in the presence of contouring variability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.